The Great British Academy of Aesthetic Medicine (BAAMed) will hold a symposium on the clinical pharmacology of botulinum toxin A in London on September 29.
The five-hour event will discuss the important aspects of toxin that is relevant in day to day practice, focusing on duration of action, dose-effect curves, product differences, dilution, spread and antigenicity.
Speaking at the symposium will be professor of neurology at Hannover Medical School, Professor Dirk Dressler and Professor Andy Pickett, who has worked with botulinum toxin for nearly 30 years.
BAAMed Founder, Dr Souphiyeh Samizadeh said, “With the rise in demand for non-surgical aesthetic procedures there is an increase in training opportunities available on the aesthetic applications of botulinum toxin A. However, much-needed knowledge of the pharmacology of botulinum toxin is missing.”
Dr Samizadeh added, “We are proud to organise and host this symposium with two of the truly world leading experts on the topic, to enable better understanding of the products available, improve clinical practice and patient safety.”
The symposium will take place at the Royal Society of Medicine on September 29.